Perspective Therapeutics CATX
NYSE CATX
$2.98 -0.14 (-4.49%)
As of: Sep 9, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025)

Perspective Therapeutics' (CATX) quarterly Other Non Operating Income came in at $1.4 million in Q1 2025, up 70100.0% quarter-over-quarter from -$2000.0 in Q4 2023.

Analysis

Perspective Therapeutics (CATX) Other Non Operating Income (2010 - 2025) Analysis & Trends

Perspective Therapeutics has disclosed Other Non Operating Income across 11 years of filings, most recently posting $1.4 million for Q1 2025.

  • In Q1 2025, Other Non Operating Income changed N/A year-over-year to $1.4 million; the TTM figure through Jun 2026 stood at $1.4 million (changed 0.14% YoY), while the FY2025 annual figure was $1.4 million, up 166.76% from the prior year.
  • Other Non Operating Income came in at $1.4 million for Q1 2025 at Perspective Therapeutics, up from -$2000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $1.4 million in Q1 2025 to a low of -$2000.0 in Q4 2023.
  • Average Other Non Operating Income over 3 years is $365500.0, with a median of $32000.0 recorded in 2022.
  • The largest YoY upside for Other Non Operating Income was 103.23% in 2023 against a maximum downside of 103.23% in 2023.
  • Over 3 years, Other Non Operating Income stood at $62000.0 in 2022, then sank by 103.23% to -$2000.0 in 2023, then soared by 70100.0% to $1.4 million in 2025.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $1.4 million in Q1 2025, -$2000.0 in Q4 2023, and $2000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Perspective Therapeutics 361.95 Mn 361.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 1.40 Mn
Dec 31, 2023 -2,000.00
Jun 30, 2023 2,000.00
Dec 31, 2022 62,000.00
Mar 31, 2019 2,000.00
Sep 30, 2016 27,000.00
Jun 30, 2016 18,000.00
Mar 31, 2016 78,000.00
Dec 31, 2015 43,000.00
Sep 30, 2015 15,000.00
Jun 30, 2015 -605.00
Mar 31, 2015 28,605.00
Dec 31, 2014 41,000.00
Sep 30, 2014 306,000.00
Jun 30, 2014 -368,134.00
Mar 31, 2014 -1.10 Mn
Dec 31, 2013 117,000.00
Sep 30, 2013 -36,000.00
Jun 30, 2013 25,000.00
Mar 31, 2013 109,000.00